RE:$0.135 by next week as excitement for new CEO builds $0.135 by next week as excitement builds for new CEO because this means the end of the Kevin Coft/Andrew Grieve era. Also, the Benne family (honest people who still hold a lot of ZENA shares) will be exercising the new policy that allows for nominations of directors other than by Zenabis management. Shai Altman will also be bringing in a new director (a VP at a billion dollar conglomerate) from his Food & Consumer Products of Canada (FCPC) network.
The Kevin Coft/Andrew Grieve era is over. Last Friday's Q2 9:31AM reissued press release "Zenabis Global loses $15.7M in Q2 2020" and subsequent short-play was Coft's last stand. Also, no more random $300K invoicing Zenabis for "financial advisory services" ($2,277,460 for 12 months ended Dec. 31, 2019***) by Andrew Grieve company Agentis Capital, something allowed by Coft but won't be allowed by Shai Altman.
The Kevin Coft/Andrew Grieve era is over and finally the full potential of Zenabis will be realized now that parasitic elements are gone.
***From SEDAR: April 2, 2020
Amounts incurred to companies affiliated with the:
Former Chief Executive Officer (Andrew Grieve) of the Company (i) $ 2,277,460
(i) Fees composed of $976,357 for staffing services and $892,356 for strategic advisory services expensed as professional fees, $382,500 for transactional services related to the $51,000,000 secured credit agreement capitalized to loans and borrowings, and $26,247 for equipment capitalized to property, plant and equipment as at December 31, 2019.
NOW WE KNOW WHY ANDREW GRIEVE WORKED FOR FREE. From '
Cannabis CEO shuns salary and bonuses to win shareholder trust', “I would much rather simply deliver shareholder value, and be paid to the extent that I deliver that value. If I don’t, I don’t. In which case, I deserve nothing,” Grieve told Yahoo Canada Finance.
And your company certainly doesn't deserve the $ 2.28M siphoned from Zenabis in 2019.